PUBLISHER: Acute Market Reports | PRODUCT CODE: 1180669
PUBLISHER: Acute Market Reports | PRODUCT CODE: 1180669
Metabolomics Market - Growth, Future Prospects and Competitive Analysis, 2022 - 2030
Metabolomics is a novel, emerging and dynamic field that studies metabolites, a distinctive chemical fingerprints produced during cellular process. Thus it identifies and quantifies metabolites further with the help of analytical technologies and application of bioinformatics extract information and analyze the same. Metabolomics though currently at nascent stage, will be widely used in biopharma and biotech industry as biomarker drug development and information. Being non-invasive in nature and closely linked to phenotype, it is an ideal tool used in agricultural industries, pharmaceutical and preventive healthcare. Rise in the number of clinical trials, awareness about nutritional products, toxicological testing data, rapid growth of metabolomics data analysis software and solutions is expected to propel the growth of this market.
The report titled "Metabolomics market - Growth, Future Prospects and Competitive Analysis, 2022-2030" offers strategic insights into the overall metabolomics market along with the market size and estimates for the duration 2020 to 2030. The said research study covers in-depth analysis of multiple market segments based on type of product and services, application, indication and different geographies. The product and services type segment studied for analyzing the overall global metabolomics market is majorly segmented into metabolomics instruments and metabolomics bioinformatics tools and services. Metabolomics instruments is sub-segmented into separation tools and detection tools. Separation tools include high-performance liquid chromatography, gas chromatography, ultra-performance liquid chromatography and capillary electrophoresis. Detection tools comprise mass spectrometry, nuclear magnetic resonance spectroscopy and surface-based mass analysis. Metabolomics bioinformatics tools and services category is sub-segmented into bioinformatics tools & databases, and bioinformatics services. The global metabolomics market is segmented by application type into biomarker discovery, drug discovery, toxicology testing, nutrigenomics, functional genomics, personalized medicine and others. Based on indications, this market is categorized into cancer, cardiovascular disorders, neurological disorders, inborn errors of metabolism and others.
Along with quantitative information, qualitative information sets and assessment tools are provided in this study for better analysis of the overall market scenario and future prospects. Information such as market inclination insights and drivers, challenges and opportunities assists the readers for understanding the ongoing trends in the global metabolomics market. Tools such as market positioning of key players and attractive investment proposition provide the readers with insights on the competitive scenario of the global metabolomics market. This report concludes with company profiles section that highlights major information about the key players engaged in global metabolomics market. In-depth competitive environment analysis and historical (2020) market size data are also provided in the report.
Metabolomics instrument occupies the largest share of global metabolomics market. Metabolomics bioinformatics tools and services is fast growing segment during the forecast period. With further technological developments, bioinformatics tools have enhanced the untargeted metabolomics workflow, enabling researchers to identify metabolite from LC/MS data and assign their biological roles with respect to chemical pathways. In separation tools segments, High-performance liquid chromatography dominates the market. While ultra-performance liquid chromatography provides high efficiency and high resolution chromatographic separation, with reduction in analysis time, hence anticipated to be fast growing market in future. Detection tool segment, mass spectrometry occupies the maximum share, with nuclear magnetic resonance spectroscopy showing fast adaptability and bright future market growth.
Biomarker discovery occupies the largest share of the global metabolomics market. Metabolomics techniques aid in discovering the potential biomarkers and providing insight into pathogeneses of numerous human diseases. With advancement in analytical technology, it possible to quantify the biomarkers from small amount of specimens using minimally invasive or non-invasive procedure, to facilitate high throughput analysis for real time application in clinical setting. Drug discovery is next followed up market for metabolomics. Metabolomics helps in diagnosing the disease by understanding the biochemical pathway, thus further aiding in drug identification, designing and customization according therapeutic needs. Personalized medicine is anticipated to be the fastest growing segment during the forecast period with biotech and pharma companies investing heavily in it research and development.
Cancer dominates the global metabolomics market by indication segmentation. Cancer study through metabolomics helps in revealing new biomarkers for cancer which would help in future diagnosis, prognosis and therapy. Cardiovascular chronic disease is the greatest public health burden globally. Thus use of metabolomic profiling would help to identify new biomarkers and mechanisms of CVD risk. Current clinical diagnosis of neurological diseases such as Parkinson's and Alzheimer diseases on basis of clinical criteria is unsatisfactory, so emerging metabolomics techniques help in discovering in now biomarker and biochemical pathway for improving the future diagnosis and determination of prognosis therapy.
North America dominates the global metabolomics market followed by Europe. The key drivers are surge in research and development funding by government and private players for metabolomics studies, rising demand for personalized medicine and toxicology testing, easy accessibility of technologically advanced products and its high adoption rate, presence of various metabolomics manufactures. Growing demand for the personalized medicine, large presence of the analytical equipment manufacturers in Europe contribute to the growth of metabolomics market. Asia Pacific has significant growth opportunity for the metabolomics market due to presence of number of pharmaceutical and biotechnology companies and its initiatives in research and development, improving health care infrastructure, emerging economies such as China, Japan, India and Singapore.
Historical & Forecast Period
This study report represents analysis of each segment from 2020 to 2030 considering 2021 as the base year. Compounded Annual Growth Rate (CAGR) for each of the respective segments estimated for the forecast period of 2022 to 2030.
The current report comprises of quantitative market estimations for each micro market for every geographical region and qualitative market analysis such as micro and macro environment analysis, market trends, competitive intelligence, segment analysis, porters five force model, top winning strategies, top investment markets, emerging trends and technological analysis, case studies, strategic conclusions and recommendations and other key market insights.
Research Methodology
The complete research study was conducted in three phases, namely: secondary research, primary research, and expert panel review. key data point that enables the estimation of Metabolomics market are as follows:
Research and development budgets of manufacturers and government spending
Revenues of key companies in the market segment
Number of end users and consumption volume, price and value.
Geographical revenues generate by countries considered in the report:
Micro and macro environment factors that are currently influencing the Metabolomics market and their expected impact during the forecast period.
Market forecast was performed through proprietary software that analyzes various qualitative and quantitative factors. Growth rate and CAGR were estimated through intensive secondary and primary research. Data triangulation across various data points provides accuracy across various analyzed market segments in the report. Application of both top down and bottom-up approach for validation of market estimation assures logical, methodical and mathematical consistency of the quantitative data.
Market Segmentation
Product and Services
Metabolomic Instruments
Separation Tools
Gas Chromatography
Ultra-Performance Liquid Chromatography
Capillary Electrophoresis
Detection Tools
Mass Spectrometry
Nuclear Magnetic Resonance Spectroscopy
Surface-Based Mass Analysis
Metabolomics Bioinformatics Tools and Services
Bioinformatics Tools & Databases
Bioinformatics Services
Application
Biomarker Discovery
Drug Discovery
Functional Genomics
Personalized Medicine
Toxicology Testing
Nutrigenomics
Others
Indication
Cancer
Cardiovascular Disorders
Neurological Disorders
Inborn Errors of Metabolism
Others
Region Segment (2020-2030; US$ Million)
North America
U.S.
Canada
Rest of North America
UK and European Union
UK
Germany
Spain
Italy
France
Rest of Europe
Asia Pacific
China
Japan
India
Australia
South Korea
Rest of Asia Pacific
Latin America
Brazil
Mexico
Rest of Latin America
Middle East and Africa
GCC
Africa
Rest of Middle East and Africa
Global Impact of Covid-19 Segment (2020-2021; US$ Million )
Pre Covid-19 situation
Post Covid-19 situation
Key questions answered in this report
What are the key micro and macro environmental factors that are impacting the growth of Metabolomics market?
What are the key investment pockets with respect to product segments and geographies currently and during the forecast period?
Estimated forecast and market projections up to 2030.
Which segment accounts for the fastest CAGR during the forecast period?
Which market segment holds a larger market share and why?
Are low and middle-income economies investing in the Metabolomics market?
Which is the largest regional market for Metabolomics market?
What are the market trends and dynamics in emerging markets such as Asia Pacific, Latin America, and Middle East & Africa?
Which are the key trends driving Metabolomics market growth?
Who are the key competitors and what are their key strategies to enhance their market presence in the Metabolomics market worldwide?
Table of Contents
1. Preface
- 1.1. Report Description
- 1.1.1. Purpose of the Report
- 1.1.2. Target Audience
- 1.1.3. Key Offerings
- 1.2. Market Segmentation
- 1.3. Research Methodology
- 1.3.1. Phase I - Secondary Research
- 1.3.2. Phase II - Primary Research
- 1.3.3. Phase III - Expert Panel Review
- 1.3.4. Assumptions
- 1.3.5. Approach Adopted
2. Executive Summary
- 2.1. Market Snapshot: Global Metabolomics Market
- 2.2. Global Metabolomics Market, By Product and Services, 2021 (US$ Million)
- 2.3. Global Metabolomics Market, By Application, 2021 (US$ Million)
- 2.4. Global Metabolomics Market, By Indication, 2021 (US$ Million)
- 2.5. Global Metabolomics Market, By Geography, 2021 (US$ Million)
- 2.6. Attractive Investment Proposition by Geography, 2021
3. Metabolomics Market: Competitive Analysis
- 3.1. Market Positioning of Key Metabolomics Market Vendors
- 3.2. Strategies Adopted by Metabolomics Market Vendors
- 3.3. Key Industry Strategies
- 3.4. Tier Analysis 2021 Versus 2030
4. Metabolomics Market: Macro Analysis & Market Dynamics
- 4.1. Introduction
- 4.2. Global Metabolomics Market Value, 2020 - 2030, (US$ Million)
- 4.3. Market Dynamics
- 4.3.1. Market Drivers
- 4.3.2. Market Restraints
- 4.3.3. Key Challenges
- 4.3.4. Key Opportunities
- 4.4. Impact Analysis of Drivers and Restraints
- 4.5. See-Saw Analysis
5. Metabolomics Market: By Product and Services, 2020-2030, USD (Million)
- 5.1. Market Overview
- 5.2. Growth & Revenue Analysis: 2021 Versus 2030
- 5.3. Market Segmentation
- 5.3.1. Metabolomic Instruments
- 5.3.1.1. Separation Tools
- 5.3.1.1.1. Gas Chromatography
- 5.3.1.1.2. Ultra-Performance Liquid Chromatography
- 5.3.1.1.3. Capillary Electrophoresis
- 5.3.1.2. Detection Tools
- 5.3.1.2.1. Mass Spectrometry
- 5.3.1.2.2. Nuclear Magnetic Resonance Spectroscopy
- 5.3.1.2.3. Surface-Based Mass Analysis
- 5.3.1.1. Separation Tools
- 5.3.2. Metabolomics Bioinformatics Tools and Services
- 5.3.2.1. Bioinformatics Tools & Databases
- 5.3.2.2. Bioinformatics Services
- 5.3.1. Metabolomic Instruments
6. Metabolomics Market: By Application, 2020-2030, USD (Million)
- 6.1. Market Overview
- 6.2. Growth & Revenue Analysis: 2021 Versus 2030
- 6.3. Market Segmentation
- 6.3.1. Biomarker Discovery
- 6.3.2. Drug Discovery
- 6.3.3. Functional Genomics
- 6.3.4. Personalized Medicine
- 6.3.5. Toxicology Testing
- 6.3.6. Nutrigenomics
- 6.3.7. Others
7. Metabolomics Market: By Indication, 2020-2030, USD (Million)
- 7.1. Market Overview
- 7.2. Growth & Revenue Analysis: 2021 Versus 2030
- 7.3. Market Segmentation
- 7.3.1. Cancer
- 7.3.2. Cardiovascular Disorders
- 7.3.3. Neurological Disorders
- 7.3.4. Inborn Errors of Metabolism
- 7.3.5. Others
8. North America Metabolomics Market, 2020-2030, USD (Million)
- 8.1. Market Overview
- 8.2. Metabolomics Market: By Product and Services, 2020-2030, USD (Million)
- 8.3. Metabolomics Market: By Application, 2020-2030, USD (Million)
- 8.4. Metabolomics Market: By Indication, 2020-2030, USD (Million)
- 8.5.Metabolomics Market: By Region, 2020-2030, USD (Million)
- 8.5.1.North America
- 8.5.1.1. U.S.
- 8.5.1.1.1. Metabolomics Market: By Product and Services, 2020-2030, USD (Million)
- 8.5.1.1.1. Metabolomics Market: By Application, 2020-2030, USD (Million)
- 8.5.1.1.1. Metabolomics Market: By Indication, 2020-2030, USD (Million)
- 8.5.1.2. Canada
- 8.5.1.2.1. Metabolomics Market: By Product and Services, 2020-2030, USD (Million)
- 8.5.1.2.1. Metabolomics Market: By Application, 2020-2030, USD (Million)
- 8.5.1.2.1. Metabolomics Market: By Indication, 2020-2030, USD (Million)
- 8.5.1.3. Rest of North America
- 8.5.1.3.1. Metabolomics Market: By Product and Services, 2020-2030, USD (Million)
- 8.5.1.3.1. Metabolomics Market: By Application, 2020-2030, USD (Million)
- 8.5.1.3.1. Metabolomics Market: By Indication, 2020-2030, USD (Million)
- 8.5.1.1. U.S.
- 8.5.1.North America
9. UK and European Union Metabolomics Market, 2020-2030, USD (Million)
- 9.1. Market Overview
- 9.2. Metabolomics Market: By Product and Services, 2020-2030, USD (Million)
- 9.3. Metabolomics Market: By Application, 2020-2030, USD (Million)
- 9.4. Metabolomics Market: By Indication, 2020-2030, USD (Million)
- 9.5.Metabolomics Market: By Region, 2020-2030, USD (Million)
- 9.5.1.UK and European Union
- 9.5.1.1. UK
- 9.5.1.1.1. Metabolomics Market: By Product and Services, 2020-2030, USD (Million)
- 9.5.1.1.1. Metabolomics Market: By Application, 2020-2030, USD (Million)
- 9.5.1.1.1. Metabolomics Market: By Indication, 2020-2030, USD (Million)
- 9.5.1.2. Germany
- 9.5.1.2.1. Metabolomics Market: By Product and Services, 2020-2030, USD (Million)
- 9.5.1.2.1. Metabolomics Market: By Application, 2020-2030, USD (Million)
- 9.5.1.2.1. Metabolomics Market: By Indication, 2020-2030, USD (Million)
- 9.5.1.3. Spain
- 9.5.1.3.1. Metabolomics Market: By Product and Services, 2020-2030, USD (Million)
- 9.5.1.3.1. Metabolomics Market: By Application, 2020-2030, USD (Million)
- 9.5.1.3.1. Metabolomics Market: By Indication, 2020-2030, USD (Million)
- 9.5.1.4. Italy
- 9.5.1.4.1. Metabolomics Market: By Product and Services, 2020-2030, USD (Million)
- 9.5.1.4.1. Metabolomics Market: By Application, 2020-2030, USD (Million)
- 9.5.1.4.1. Metabolomics Market: By Indication, 2020-2030, USD (Million)
- 9.5.1.5. France
- 9.5.1.5.1. Metabolomics Market: By Product and Services, 2020-2030, USD (Million)
- 9.5.1.5.1. Metabolomics Market: By Application, 2020-2030, USD (Million)
- 9.5.1.5.1. Metabolomics Market: By Indication, 2020-2030, USD (Million)
- 9.5.1.6. Rest of Europe
- 9.5.1.6.1. Metabolomics Market: By Product and Services, 2020-2030, USD (Million)
- 9.5.1.6.1. Metabolomics Market: By Application, 2020-2030, USD (Million)
- 9.5.1.6.1. Metabolomics Market: By Indication, 2020-2030, USD (Million)
- 9.5.1.1. UK
- 9.5.1.UK and European Union
10. Asia Pacific Metabolomics Market, 2020-2030, USD (Million)
- 10.1. Market Overview
- 10.2. Metabolomics Market: By Product and Services, 2020-2030, USD (Million)
- 10.3. Metabolomics Market: By Application, 2020-2030, USD (Million)
- 10.4. Metabolomics Market: By Indication, 2020-2030, USD (Million)
- 10.5.Metabolomics Market: By Region, 2020-2030, USD (Million)
- 10.5.1.Asia Pacific
- 10.5.1.1. China
- 10.5.1.1.1. Metabolomics Market: By Product and Services, 2020-2030, USD (Million)
- 10.5.1.1.1. Metabolomics Market: By Application, 2020-2030, USD (Million)
- 10.5.1.1.1. Metabolomics Market: By Indication, 2020-2030, USD (Million)
- 10.5.1.2. Japan
- 10.5.1.2.1. Metabolomics Market: By Product and Services, 2020-2030, USD (Million)
- 10.5.1.2.1. Metabolomics Market: By Application, 2020-2030, USD (Million)
- 10.5.1.2.1. Metabolomics Market: By Indication, 2020-2030, USD (Million)
- 10.5.1.3. India
- 10.5.1.3.1. Metabolomics Market: By Product and Services, 2020-2030, USD (Million)
- 10.5.1.3.1. Metabolomics Market: By Application, 2020-2030, USD (Million)
- 10.5.1.3.1. Metabolomics Market: By Indication, 2020-2030, USD (Million)
- 10.5.1.4. Australia
- 10.5.1.4.1. Metabolomics Market: By Product and Services, 2020-2030, USD (Million)
- 10.5.1.4.1. Metabolomics Market: By Application, 2020-2030, USD (Million)
- 10.5.1.4.1. Metabolomics Market: By Indication, 2020-2030, USD (Million)
- 10.5.1.5. South Korea
- 10.5.1.5.1. Metabolomics Market: By Product and Services, 2020-2030, USD (Million)
- 10.5.1.5.1. Metabolomics Market: By Application, 2020-2030, USD (Million)
- 10.5.1.5.1. Metabolomics Market: By Indication, 2020-2030, USD (Million)
- 10.5.1.6. Rest of Asia Pacific
- 10.5.1.6.1. Metabolomics Market: By Product and Services, 2020-2030, USD (Million)
- 10.5.1.6.1. Metabolomics Market: By Application, 2020-2030, USD (Million)
- 10.5.1.6.1. Metabolomics Market: By Indication, 2020-2030, USD (Million)
- 10.5.1.1. China
- 10.5.1.Asia Pacific
11. Latin America Metabolomics Market, 2020-2030, USD (Million)
- 11.1. Market Overview
- 11.2. Metabolomics Market: By Product and Services, 2020-2030, USD (Million)
- 11.3. Metabolomics Market: By Application, 2020-2030, USD (Million)
- 11.4. Metabolomics Market: By Indication, 2020-2030, USD (Million)
- 11.5.Metabolomics Market: By Region, 2020-2030, USD (Million)
- 11.5.1.Latin America
- 11.5.1.1. Brazil
- 11.5.1.1.1. Metabolomics Market: By Product and Services, 2020-2030, USD (Million)
- 11.5.1.1.1. Metabolomics Market: By Application, 2020-2030, USD (Million)
- 11.5.1.1.1. Metabolomics Market: By Indication, 2020-2030, USD (Million)
- 11.5.1.2. Mexico
- 11.5.1.2.1. Metabolomics Market: By Product and Services, 2020-2030, USD (Million)
- 11.5.1.2.1. Metabolomics Market: By Application, 2020-2030, USD (Million)
- 11.5.1.2.1. Metabolomics Market: By Indication, 2020-2030, USD (Million)
- 11.5.1.3. Rest of Latin America
- 11.5.1.3.1. Metabolomics Market: By Product and Services, 2020-2030, USD (Million)
- 11.5.1.3.1. Metabolomics Market: By Application, 2020-2030, USD (Million)
- 11.5.1.3.1. Metabolomics Market: By Indication, 2020-2030, USD (Million)
- 11.5.1.1. Brazil
- 11.5.1.Latin America
12. Middle East and Africa Metabolomics Market, 2020-2030, USD (Million)
- 12.1. Market Overview
- 12.2. Metabolomics Market: By Product and Services, 2020-2030, USD (Million)
- 12.3. Metabolomics Market: By Application, 2020-2030, USD (Million)
- 12.4. Metabolomics Market: By Indication, 2020-2030, USD (Million)
- 12.5.Metabolomics Market: By Region, 2020-2030, USD (Million)
- 12.5.1.Middle East and Africa
- 12.5.1.1. GCC
- 12.5.1.1.1. Metabolomics Market: By Product and Services, 2020-2030, USD (Million)
- 12.5.1.1.1. Metabolomics Market: By Application, 2020-2030, USD (Million)
- 12.5.1.1.1. Metabolomics Market: By Indication, 2020-2030, USD (Million)
- 12.5.1.2. Africa
- 12.5.1.2.1. Metabolomics Market: By Product and Services, 2020-2030, USD (Million)
- 12.5.1.2.1. Metabolomics Market: By Application, 2020-2030, USD (Million)
- 12.5.1.2.1. Metabolomics Market: By Indication, 2020-2030, USD (Million)
- 12.5.1.3. Rest of Middle East and Africa
- 12.5.1.3.1. Metabolomics Market: By Product and Services, 2020-2030, USD (Million)
- 12.5.1.3.1. Metabolomics Market: By Application, 2020-2030, USD (Million)
- 12.5.1.3.1. Metabolomics Market: By Indication, 2020-2030, USD (Million)
- 12.5.1.1. GCC
- 12.5.1.Middle East and Africa
13. Company Profile
- 13.1. Agilent Technologies, Inc.
- 13.1.1. Company Overview
- 13.1.2. Financial Performance
- 13.1.3. Product Portfolio
- 13.1.4. Strategic Initiatives
- 13.2. Acureomics AB
- 13.2.1. Company Overview
- 13.2.2. Financial Performance
- 13.2.3. Product Portfolio
- 13.2.4. Strategic Initiatives
- 13.3. Amatsi Group
- 13.3.1. Company Overview
- 13.3.2. Financial Performance
- 13.3.3. Product Portfolio
- 13.3.4. Strategic Initiatives
- 13.4. Bayer, Inc.
- 13.4.1. Company Overview
- 13.4.2. Financial Performance
- 13.4.3. Product Portfolio
- 13.4.4. Strategic Initiatives
- 13.5. Berg LLC
- 13.5.1. Company Overview
- 13.5.2. Financial Performance
- 13.5.3. Product Portfolio
- 13.5.4. Strategic Initiatives
- 13.6. Biocrates Life Sciences AG
- 13.6.1. Company Overview
- 13.6.2. Financial Performance
- 13.6.3. Product Portfolio
- 13.6.4. Strategic Initiatives
- 13.7. Bio-Rad Laboratories, Inc.
- 13.7.1. Company Overview
- 13.7.2. Financial Performance
- 13.7.3. Product Portfolio
- 13.7.4. Strategic Initiatives
- 13.8. Bruker Corporation
- 13.8.1. Company Overview
- 13.8.2. Financial Performance
- 13.8.3. Product Portfolio
- 13.8.4. Strategic Initiatives
- 13.9. Chenomx,Inc
- 13.9.1. Company Overview
- 13.9.2. Financial Performance
- 13.9.3. Product Portfolio
- 13.9.4. Strategic Initiatives
- 13.10. Danher Corporation
- 13.10.1. Company Overview
- 13.10.2. Financial Performance
- 13.10.3. Product Portfolio
- 13.10.4. Strategic Initiatives
- 13.11. Human Metabolome Technologies, Inc.
- 13.11.1. Company Overview
- 13.11.2. Financial Performance
- 13.11.3. Product Portfolio
- 13.11.4. Strategic Initiatives
- 13.12. HepatoChem, Inc.
- 13.12.1. Company Overview
- 13.12.2. Financial Performance
- 13.12.3. Product Portfolio
- 13.12.4. Strategic Initiatives
- 13.13. IROA Technologies
- 13.13.1. Company Overview
- 13.13.2. Financial Performance
- 13.13.3. Product Portfolio
- 13.13.4. Strategic Initiatives
- 13.14. Leco Corporation
- 13.14.1. Company Overview
- 13.14.2. Financial Performance
- 13.14.3. Product Portfolio
- 13.14.4. Strategic Initiatives
- 13.15. Metabolon, Inc.
- 13.15.1. Company Overview
- 13.15.2. Financial Performance
- 13.15.3. Product Portfolio
- 13.15.4. Strategic Initiatives
- 13.16. Max Planck Society
- 13.16.1. Company Overview
- 13.16.2. Financial Performance
- 13.16.3. Product Portfolio
- 13.16.4. Strategic Initiatives
- 13.17. Metabolomic Discoveries GmbH
- 13.17.1. Company Overview
- 13.17.2. Financial Performance
- 13.17.3. Product Portfolio
- 13.17.4. Strategic Initiatives
- 13.18. Metabolomx
- 13.18.1. Company Overview
- 13.18.2. Financial Performance
- 13.18.3. Product Portfolio
- 13.18.4. Strategic Initiatives
- 13.19. Metabometrix Ltd.
- 13.19.1. Company Overview
- 13.19.2. Financial Performance
- 13.19.3. Product Portfolio
- 13.19.4. Strategic Initiatives
- 13.20. Metanomics GmbH
- 13.20.1. Company Overview
- 13.20.2. Financial Performance
- 13.20.3. Product Portfolio
- 13.20.4. Strategic Initiatives
- 13.21. Phenomenome Discoveries, Inc.
- 13.21.1. Company Overview
- 13.21.2. Financial Performance
- 13.21.3. Product Portfolio
- 13.21.4. Strategic Initiatives
- 13.22. SCIEX
- 13.22.1. Company Overview
- 13.22.2. Financial Performance
- 13.22.3. Product Portfolio
- 13.22.4. Strategic Initiatives
- 13.23. Shimadzu Corporation
- 13.23.1. Company Overview
- 13.23.2. Financial Performance
- 13.23.3. Product Portfolio
- 13.23.4. Strategic Initiatives
- 13.24. SiDMAP
- 13.24.1. Company Overview
- 13.24.2. Financial Performance
- 13.24.3. Product Portfolio
- 13.24.4. Strategic Initiatives
- 13.25. Stemina Biomarker Discovery, Inc
- 13.25.1. Company Overview
- 13.25.2. Financial Performance
- 13.25.3. Product Portfolio
- 13.25.4. Strategic Initiatives
- 13.26. Thermo Fisher Scientific, Inc.
- 13.26.1. Company Overview
- 13.26.2. Financial Performance
- 13.26.3. Product Portfolio
- 13.26.4. Strategic Initiatives
- 13.27. Waters Corporation
- 13.27.1. Company Overview
- 13.27.2. Financial Performance
- 13.27.3. Product Portfolio
- 13.27.4. Strategic Initiatives
- 13.28. Xceleron, Inc.
- 13.28.1. Company Overview
- 13.28.2. Financial Performance
- 13.28.3. Product Portfolio
- 13.28.4. Strategic Initiatives
- 13.29. Other Notable Players
- 13.29.1. Company Overview
- 13.29.2. Financial Performance
- 13.29.3. Product Portfolio
- 13.29.4. Strategic Initiatives
List of Tables
- TABLE 1 Global Metabolomics Market By Product and Services, 2020-2030, USD (Million)
- TABLE 2 Global Metabolomics Market By Metabolomic Instruments, 2020-2030, USD (Million)
- TABLE 3 Global Metabolomics Market By Separation Tools, 2020-2030, USD (Million)
- TABLE 4 Global Metabolomics Market By Detection Tools, 2020-2030, USD (Million)
- TABLE 5 Global Metabolomics Market By Metabolomics Bioinformatics Tools and Services, 2020-2030, USD (Million)
- TABLE 6 Global Metabolomics Market By Application, 2020-2030, USD (Million)
- TABLE 7 Global Metabolomics Market By Indication, 2020-2030, USD (Million)
- TABLE 8 North America Metabolomics Market By Product and Services, 2020-2030, USD (Million)
- TABLE 9 North America Metabolomics Market By Metabolomic Instruments, 2020-2030, USD (Million)
- TABLE 10 North America Metabolomics Market By Separation Tools, 2020-2030, USD (Million)
- TABLE 11 North America Metabolomics Market By Detection Tools, 2020-2030, USD (Million)
- TABLE 12 North America Metabolomics Market By Metabolomics Bioinformatics Tools and Services, 2020-2030, USD (Million)
- TABLE 13 North America Metabolomics Market By Application, 2020-2030, USD (Million)
- TABLE 14 North America Metabolomics Market By Indication, 2020-2030, USD (Million)
- TABLE 15 U.S. Metabolomics Market By Product and Services, 2020-2030, USD (Million)
- TABLE 16 U.S. Metabolomics Market By Metabolomic Instruments, 2020-2030, USD (Million)
- TABLE 17 U.S. Metabolomics Market By Separation Tools, 2020-2030, USD (Million)
- TABLE 18 U.S. Metabolomics Market By Detection Tools, 2020-2030, USD (Million)
- TABLE 19 U.S. Metabolomics Market By Metabolomics Bioinformatics Tools and Services, 2020-2030, USD (Million)
- TABLE 20 U.S. Metabolomics Market By Application, 2020-2030, USD (Million)
- TABLE 21 U.S. Metabolomics Market By Indication, 2020-2030, USD (Million)
- TABLE 22 Canada Metabolomics Market By Product and Services, 2020-2030, USD (Million)
- TABLE 23 Canada Metabolomics Market By Metabolomic Instruments, 2020-2030, USD (Million)
- TABLE 24 Canada Metabolomics Market By Separation Tools, 2020-2030, USD (Million)
- TABLE 25 Canada Metabolomics Market By Detection Tools, 2020-2030, USD (Million)
- TABLE 26 Canada Metabolomics Market By Metabolomics Bioinformatics Tools and Services, 2020-2030, USD (Million)
- TABLE 27 Canada Metabolomics Market By Application, 2020-2030, USD (Million)
- TABLE 28 Canada Metabolomics Market By Indication, 2020-2030, USD (Million)
- TABLE 29 Rest of North America Metabolomics Market By Product and Services, 2020-2030, USD (Million)
- TABLE 30 Rest of North America Metabolomics Market By Metabolomic Instruments, 2020-2030, USD (Million)
- TABLE 31 Rest of North America Metabolomics Market By Separation Tools, 2020-2030, USD (Million)
- TABLE 32 Rest of North America Metabolomics Market By Detection Tools, 2020-2030, USD (Million)
- TABLE 33 Rest of North America Metabolomics Market By Metabolomics Bioinformatics Tools and Services, 2020-2030, USD (Million)
- TABLE 34 Rest of North America Metabolomics Market By Application, 2020-2030, USD (Million)
- TABLE 35 Rest of North America Metabolomics Market By Indication, 2020-2030, USD (Million)
- TABLE 36 UK and European Union Metabolomics Market By Product and Services, 2020-2030, USD (Million)
- TABLE 37 UK and European Union Metabolomics Market By Metabolomic Instruments, 2020-2030, USD (Million)
- TABLE 38 UK and European Union Metabolomics Market By Separation Tools, 2020-2030, USD (Million)
- TABLE 39 UK and European Union Metabolomics Market By Detection Tools, 2020-2030, USD (Million)
- TABLE 40 UK and European Union Metabolomics Market By Metabolomics Bioinformatics Tools and Services, 2020-2030, USD (Million)
- TABLE 41 UK and European Union Metabolomics Market By Application, 2020-2030, USD (Million)
- TABLE 42 UK and European Union Metabolomics Market By Indication, 2020-2030, USD (Million)
- TABLE 43 UK Metabolomics Market By Product and Services, 2020-2030, USD (Million)
- TABLE 44 UK Metabolomics Market By Metabolomic Instruments, 2020-2030, USD (Million)
- TABLE 45 UK Metabolomics Market By Separation Tools, 2020-2030, USD (Million)
- TABLE 46 UK Metabolomics Market By Detection Tools, 2020-2030, USD (Million)
- TABLE 47 UK Metabolomics Market By Metabolomics Bioinformatics Tools and Services, 2020-2030, USD (Million)
- TABLE 48 UK Metabolomics Market By Application, 2020-2030, USD (Million)
- TABLE 49 UK Metabolomics Market By Indication, 2020-2030, USD (Million)
- TABLE 50 Germany Metabolomics Market By Product and Services, 2020-2030, USD (Million)
- TABLE 51 Germany Metabolomics Market By Metabolomic Instruments, 2020-2030, USD (Million)
- TABLE 52 Germany Metabolomics Market By Separation Tools, 2020-2030, USD (Million)
- TABLE 53 Germany Metabolomics Market By Detection Tools, 2020-2030, USD (Million)
- TABLE 54 Germany Metabolomics Market By Metabolomics Bioinformatics Tools and Services, 2020-2030, USD (Million)
- TABLE 55 Germany Metabolomics Market By Application, 2020-2030, USD (Million)
- TABLE 56 Germany Metabolomics Market By Indication, 2020-2030, USD (Million)
- TABLE 57 Spain Metabolomics Market By Product and Services, 2020-2030, USD (Million)
- TABLE 58 Spain Metabolomics Market By Metabolomic Instruments, 2020-2030, USD (Million)
- TABLE 59 Spain Metabolomics Market By Separation Tools, 2020-2030, USD (Million)
- TABLE 60 Spain Metabolomics Market By Detection Tools, 2020-2030, USD (Million)
- TABLE 61 Spain Metabolomics Market By Metabolomics Bioinformatics Tools and Services, 2020-2030, USD (Million)
- TABLE 62 Spain Metabolomics Market By Application, 2020-2030, USD (Million)
- TABLE 63 Spain Metabolomics Market By Indication, 2020-2030, USD (Million)
- TABLE 64 Italy Metabolomics Market By Product and Services, 2020-2030, USD (Million)
- TABLE 65 Italy Metabolomics Market By Metabolomic Instruments, 2020-2030, USD (Million)
- TABLE 66 Italy Metabolomics Market By Separation Tools, 2020-2030, USD (Million)
- TABLE 67 Italy Metabolomics Market By Detection Tools, 2020-2030, USD (Million)
- TABLE 68 Italy Metabolomics Market By Metabolomics Bioinformatics Tools and Services, 2020-2030, USD (Million)
- TABLE 69 Italy Metabolomics Market By Application, 2020-2030, USD (Million)
- TABLE 70 Italy Metabolomics Market By Indication, 2020-2030, USD (Million)
- TABLE 71 France Metabolomics Market By Product and Services, 2020-2030, USD (Million)
- TABLE 72 France Metabolomics Market By Metabolomic Instruments, 2020-2030, USD (Million)
- TABLE 73 France Metabolomics Market By Separation Tools, 2020-2030, USD (Million)
- TABLE 74 France Metabolomics Market By Detection Tools, 2020-2030, USD (Million)
- TABLE 75 France Metabolomics Market By Metabolomics Bioinformatics Tools and Services, 2020-2030, USD (Million)
- TABLE 76 France Metabolomics Market By Application, 2020-2030, USD (Million)
- TABLE 77 France Metabolomics Market By Indication, 2020-2030, USD (Million)
- TABLE 78 Rest of Europe Metabolomics Market By Product and Services, 2020-2030, USD (Million)
- TABLE 79 Rest of Europe Metabolomics Market By Metabolomic Instruments, 2020-2030, USD (Million)
- TABLE 80 Rest of Europe Metabolomics Market By Separation Tools, 2020-2030, USD (Million)
- TABLE 81 Rest of Europe Metabolomics Market By Detection Tools, 2020-2030, USD (Million)
- TABLE 82 Rest of Europe Metabolomics Market By Metabolomics Bioinformatics Tools and Services, 2020-2030, USD (Million)
- TABLE 83 Rest of Europe Metabolomics Market By Application, 2020-2030, USD (Million)
- TABLE 84 Rest of Europe Metabolomics Market By Indication, 2020-2030, USD (Million)
- TABLE 85 Asia Metabolomics Market By Product and Services, 2020-2030, USD (Million)
- TABLE 86 Asia Metabolomics Market By Metabolomic Instruments, 2020-2030, USD (Million)
- TABLE 87 Asia Metabolomics Market By Separation Tools, 2020-2030, USD (Million)
- TABLE 88 Asia Metabolomics Market By Detection Tools, 2020-2030, USD (Million)
- TABLE 89 Asia Metabolomics Market By Metabolomics Bioinformatics Tools and Services, 2020-2030, USD (Million)
- TABLE 90 Asia Metabolomics Market By Application, 2020-2030, USD (Million)
- TABLE 91 Asia Metabolomics Market By Indication, 2020-2030, USD (Million)
- TABLE 92 China Metabolomics Market By Product and Services, 2020-2030, USD (Million)
- TABLE 93 China Metabolomics Market By Metabolomic Instruments, 2020-2030, USD (Million)
- TABLE 94 China Metabolomics Market By Separation Tools, 2020-2030, USD (Million)
- TABLE 95 China Metabolomics Market By Detection Tools, 2020-2030, USD (Million)
- TABLE 96 China Metabolomics Market By Metabolomics Bioinformatics Tools and Services, 2020-2030, USD (Million)
- TABLE 97 China Metabolomics Market By Application, 2020-2030, USD (Million)
- TABLE 98 China Metabolomics Market By Indication, 2020-2030, USD (Million)
- TABLE 99 Japan Metabolomics Market By Product and Services, 2020-2030, USD (Million)
- TABLE 100 Japan Metabolomics Market By Metabolomic Instruments, 2020-2030, USD (Million)
- TABLE 101 Japan Metabolomics Market By Separation Tools, 2020-2030, USD (Million)
- TABLE 102 Japan Metabolomics Market By Detection Tools, 2020-2030, USD (Million)
- TABLE 103 Japan Metabolomics Market By Metabolomics Bioinformatics Tools and Services, 2020-2030, USD (Million)
- TABLE 104 Japan Metabolomics Market By Application, 2020-2030, USD (Million)
- TABLE 105 Japan Metabolomics Market By Indication, 2020-2030, USD (Million)
- TABLE 106 India Metabolomics Market By Product and Services, 2020-2030, USD (Million)
- TABLE 107 India Metabolomics Market By Metabolomic Instruments, 2020-2030, USD (Million)
- TABLE 108 India Metabolomics Market By Separation Tools, 2020-2030, USD (Million)
- TABLE 109 India Metabolomics Market By Detection Tools, 2020-2030, USD (Million)
- TABLE 110 India Metabolomics Market By Metabolomics Bioinformatics Tools and Services, 2020-2030, USD (Million)
- TABLE 111 India Metabolomics Market By Application, 2020-2030, USD (Million)
- TABLE 112 India Metabolomics Market By Indication, 2020-2030, USD (Million)
- TABLE 113 Australia Metabolomics Market By Product and Services, 2020-2030, USD (Million)
- TABLE 114 Australia Metabolomics Market By Metabolomic Instruments, 2020-2030, USD (Million)
- TABLE 115 Australia Metabolomics Market By Separation Tools, 2020-2030, USD (Million)
- TABLE 116 Australia Metabolomics Market By Detection Tools, 2020-2030, USD (Million)
- TABLE 117 Australia Metabolomics Market By Metabolomics Bioinformatics Tools and Services, 2020-2030, USD (Million)
- TABLE 118 Australia Metabolomics Market By Application, 2020-2030, USD (Million)
- TABLE 119 Australia Metabolomics Market By Indication, 2020-2030, USD (Million)
- TABLE 120 South Korea Metabolomics Market By Product and Services, 2020-2030, USD (Million)
- TABLE 121 South Korea Metabolomics Market By Metabolomic Instruments, 2020-2030, USD (Million)
- TABLE 122 South Korea Metabolomics Market By Separation Tools, 2020-2030, USD (Million)
- TABLE 123 South Korea Metabolomics Market By Detection Tools, 2020-2030, USD (Million)
- TABLE 124 South Korea Metabolomics Market By Metabolomics Bioinformatics Tools and Services, 2020-2030, USD (Million)
- TABLE 125 South Korea Metabolomics Market By Application, 2020-2030, USD (Million)
- TABLE 126 South Korea Metabolomics Market By Indication, 2020-2030, USD (Million)
- TABLE 127 Latin America Metabolomics Market By Product and Services, 2020-2030, USD (Million)
- TABLE 128 Latin America Metabolomics Market By Metabolomic Instruments, 2020-2030, USD (Million)
- TABLE 129 Latin America Metabolomics Market By Separation Tools, 2020-2030, USD (Million)
- TABLE 130 Latin America Metabolomics Market By Detection Tools, 2020-2030, USD (Million)
- TABLE 131 Latin America Metabolomics Market By Metabolomics Bioinformatics Tools and Services, 2020-2030, USD (Million)
- TABLE 132 Latin America Metabolomics Market By Application, 2020-2030, USD (Million)
- TABLE 133 Latin America Metabolomics Market By Indication, 2020-2030, USD (Million)
- TABLE 134 Brazil Metabolomics Market By Product and Services, 2020-2030, USD (Million)
- TABLE 135 Brazil Metabolomics Market By Metabolomic Instruments, 2020-2030, USD (Million)
- TABLE 136 Brazil Metabolomics Market By Separation Tools, 2020-2030, USD (Million)
- TABLE 137 Brazil Metabolomics Market By Detection Tools, 2020-2030, USD (Million)
- TABLE 138 Brazil Metabolomics Market By Metabolomics Bioinformatics Tools and Services, 2020-2030, USD (Million)
- TABLE 139 Brazil Metabolomics Market By Application, 2020-2030, USD (Million)
- TABLE 140 Brazil Metabolomics Market By Indication, 2020-2030, USD (Million)
- TABLE 141 Mexico Metabolomics Market By Product and Services, 2020-2030, USD (Million)
- TABLE 142 Mexico Metabolomics Market By Metabolomic Instruments, 2020-2030, USD (Million)
- TABLE 143 Mexico Metabolomics Market By Separation Tools, 2020-2030, USD (Million)
- TABLE 144 Mexico Metabolomics Market By Detection Tools, 2020-2030, USD (Million)
- TABLE 145 Mexico Metabolomics Market By Metabolomics Bioinformatics Tools and Services, 2020-2030, USD (Million)
- TABLE 146 Mexico Metabolomics Market By Application, 2020-2030, USD (Million)
- TABLE 147 Mexico Metabolomics Market By Indication, 2020-2030, USD (Million)
- TABLE 148 Rest of Latin America Metabolomics Market By Product and Services, 2020-2030, USD (Million)
- TABLE 149 Rest of Latin America Metabolomics Market By Metabolomic Instruments, 2020-2030, USD (Million)
- TABLE 150 Rest of Latin America Metabolomics Market By Separation Tools, 2020-2030, USD (Million)
- TABLE 151 Rest of Latin America Metabolomics Market By Detection Tools, 2020-2030, USD (Million)
- TABLE 152 Rest of Latin America Metabolomics Market By Metabolomics Bioinformatics Tools and Services, 2020-2030, USD (Million)
- TABLE 153 Rest of Latin America Metabolomics Market By Application, 2020-2030, USD (Million)
- TABLE 154 Rest of Latin America Metabolomics Market By Indication, 2020-2030, USD (Million)
- TABLE 155 Middle East and Africa Metabolomics Market By Product and Services, 2020-2030, USD (Million)
- TABLE 156 Middle East and Africa Metabolomics Market By Metabolomic Instruments, 2020-2030, USD (Million)
- TABLE 157 Middle East and Africa Metabolomics Market By Separation Tools, 2020-2030, USD (Million)
- TABLE 158 Middle East and Africa Metabolomics Market By Detection Tools, 2020-2030, USD (Million)
- TABLE 159 Middle East and Africa Metabolomics Market By Metabolomics Bioinformatics Tools and Services, 2020-2030, USD (Million)
- TABLE 160 Middle East and Africa Metabolomics Market By Application, 2020-2030, USD (Million)
- TABLE 161 Middle East and Africa Metabolomics Market By Indication, 2020-2030, USD (Million)
- TABLE 162 GCC Metabolomics Market By Product and Services, 2020-2030, USD (Million)
- TABLE 163 GCC Metabolomics Market By Metabolomic Instruments, 2020-2030, USD (Million)
- TABLE 164 GCC Metabolomics Market By Separation Tools, 2020-2030, USD (Million)
- TABLE 165 GCC Metabolomics Market By Detection Tools, 2020-2030, USD (Million)
- TABLE 166 GCC Metabolomics Market By Metabolomics Bioinformatics Tools and Services, 2020-2030, USD (Million)
- TABLE 167 GCC Metabolomics Market By Application, 2020-2030, USD (Million)
- TABLE 168 GCC Metabolomics Market By Indication, 2020-2030, USD (Million)
- TABLE 169 Africa Metabolomics Market By Product and Services, 2020-2030, USD (Million)
- TABLE 170 Africa Metabolomics Market By Metabolomic Instruments, 2020-2030, USD (Million)
- TABLE 171 Africa Metabolomics Market By Separation Tools, 2020-2030, USD (Million)
- TABLE 172 Africa Metabolomics Market By Detection Tools, 2020-2030, USD (Million)
- TABLE 173 Africa Metabolomics Market By Metabolomics Bioinformatics Tools and Services, 2020-2030, USD (Million)
- TABLE 174 Africa Metabolomics Market By Application, 2020-2030, USD (Million)
- TABLE 175 Africa Metabolomics Market By Indication, 2020-2030, USD (Million)
- TABLE 176 Rest of Middle East and Africa Metabolomics Market By Product and Services, 2020-2030, USD (Million)
- TABLE 177 Rest of Middle East and Africa Metabolomics Market By Metabolomic Instruments, 2020-2030, USD (Million)
- TABLE 178 Rest of Middle East and Africa Metabolomics Market By Separation Tools, 2020-2030, USD (Million)
- TABLE 179 Rest of Middle East and Africa Metabolomics Market By Detection Tools, 2020-2030, USD (Million)
- TABLE 180 Rest of Middle East and Africa Metabolomics Market By Metabolomics Bioinformatics Tools and Services, 2020-2030, USD (Million)
- TABLE 181 Rest of Middle East and Africa Metabolomics Market By Application, 2020-2030, USD (Million)
- TABLE 182 Rest of Middle East and Africa Metabolomics Market By Indication, 2020-2030, USD (Million)
List of Figures
- FIG. 1 Global Metabolomics Market: Market Coverage
- FIG. 2 Research Methodology and Data Sources
- FIG. 3 Market Size Estimation - Top Down & Bottom-Up Approach
- FIG. 4 Global Metabolomics Market: Quality Assurance
- FIG. 5 Global Metabolomics Market, By Product and Services, 2021
- FIG. 6 Global Metabolomics Market, By Application, 2021
- FIG. 7 Global Metabolomics Market, By Indication, 2021
- FIG. 8 Global Metabolomics Market, By Geography, 2021
- FIG. 9 Market Geographical Opportunity Matrix - Global Metabolomics Market, 2021
- FIG. 10 Market Positioning of Key Metabolomics Market Players, 2021
- FIG. 11 Global Metabolomics Market - Tier Analysis - Percentage of Revenues by Tier Level, 2021 Versus 2030
- FIG. 12 Global Metabolomics Market, By Product and Services, 2021 Vs 2030, %
- FIG. 13 Global Metabolomics Market, By Application, 2021 Vs 2030, %
- FIG. 14 Global Metabolomics Market, By Indication, 2021 Vs 2030, %
- FIG. 15 U.S. Metabolomics Market (US$ Million), 2020 - 2030
- FIG. 16 Canada Metabolomics Market (US$ Million), 2020 - 2030
- FIG. 17 Rest of North America Metabolomics Market (US$ Million), 2020 - 2030
- FIG. 18 UK Metabolomics Market (US$ Million), 2020 - 2030
- FIG. 19 Germany Metabolomics Market (US$ Million), 2020 - 2030
- FIG. 20 Spain Metabolomics Market (US$ Million), 2020 - 2030
- FIG. 21 Italy Metabolomics Market (US$ Million), 2020 - 2030
- FIG. 22 France Metabolomics Market (US$ Million), 2020 - 2030
- FIG. 23 Rest of Europe Metabolomics Market (US$ Million), 2020 - 2030
- FIG. 24 China Metabolomics Market (US$ Million), 2020 - 2030
- FIG. 25 Japan Metabolomics Market (US$ Million), 2020 - 2030
- FIG. 26 India Metabolomics Market (US$ Million), 2020 - 2030
- FIG. 27 Australia Metabolomics Market (US$ Million), 2020 - 2030
- FIG. 28 South Korea Metabolomics Market (US$ Million), 2020 - 2030
- FIG. 29 Rest of Asia Metabolomics Market (US$ Million), 2020 - 2030
- FIG. 30 Brazil Metabolomics Market (US$ Million), 2020 - 2030
- FIG. 31 Mexico Metabolomics Market (US$ Million), 2020 - 2030
- FIG. 32 Rest of Latin America Metabolomics Market (US$ Million), 2020 - 2030
- FIG. 33 GCC Metabolomics Market (US$ Million), 2020 - 2030
- FIG. 34 Africa Metabolomics Market (US$ Million), 2020 - 2030
- FIG. 35 Rest of Middle East and Africa Metabolomics Market (US$ Million), 2020 - 2030
